UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 441

Sortiert nach

A MALT lymphoma prognostic index

Blood, 2017-09, Vol.130 (12), p.1409-1417

2017

Volltextzugriff (PDF)

Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI

British journal of haematology, 2017-03, Vol.176 (6), p.918-928

2017

Volltextzugriff (PDF)

Increased tumour angiogenesis in SOX11‐positive mantle cell lymphoma

Histopathology, 2019-11, Vol.75 (5), p.704-714

2019

Volltextzugriff (PDF)

High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation

Journal of Clinical and Experimental Hematopathology, 2019, Vol.59(1), pp.1-16

2019

Volltextzugriff (PDF)

Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas

British journal of haematology, 2008-03, Vol.140 (5), p.516-526

2008

Volltextzugriff (PDF)

Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation Signature

Journal of clinical oncology, 2007-04, Vol.25 (10), p.1216-1222

2007

Volltextzugriff (PDF)

P1107: ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e6350662-n/a

2023

Volltextzugriff (PDF)

Survival analysis in hematologic malignancies: recommendations for clinicians

Haematologica (Roma), 2014-09, Vol.99 (9), p.1410

2014

Volltextzugriff (PDF)

Adult haemophagocytic syndrome

The Lancet (British edition), 2014-04, Vol.383 (9927), p.1503-1516

2014

Volltextzugriff (PDF)

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Journal of clinical oncology, 2017-06, Vol.35 (17), p.1905-1912

2017

Volltextzugriff (PDF)

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4555-4562

2009

Volltextzugriff (PDF)

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma

Modern pathology, 2017-05, Vol.30 (5), p.745-760

2017

Volltextzugriff (PDF)

Minimal residual disease – ready for prime time in follicular lymphoma?

British journal of haematology, 2020-01, Vol.188 (2), p.205-206

2020

Volltextzugriff (PDF)

High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1470-1476

2009

Volltextzugriff (PDF)

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2766-2772

2011

Volltextzugriff (PDF)

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

British journal of haematology, 2019-03, Vol.184 (5), p.753-759

2019

Volltextzugriff (PDF)

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

British journal of haematology, 2017-09, Vol.178 (5), p.699-708

2017

Volltextzugriff (PDF)

1 – 25 von 441

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(389)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Life Sciences & Biomedicine
(256)
Humans
(241)
Male
(165)
Female
(159)
Middle Aged
(159)
Hematology
(154)
Aged
(143)
Adult
(132)
Oncology
(106)
Prognosis
(106)
Biological And Medical Sciences
(88)
Medical Sciences
(88)
Aged, 80 And Over
(84)
Lymphoma
(74)
Hematologic And Hematopoietic Diseases
(73)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(71)
Treatment Outcome
(51)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(46)
Survival Analysis
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A MALT lymphoma prognostic index

Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI

Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, PD‐L1 copy number alterations, and outcome

Increased tumour angiogenesis in SOX11‐positive mantle cell lymphoma

High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation

Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)

Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas

Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation Signature

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

P1107: ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Survival analysis in hematologic malignancies: recommendations for clinicians

P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR‐CEL) IN RELAPSED/ REFRACTORY CD19+ NON‐HODGKIN LYMPHOMA

Adult haemophagocytic syndrome

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma

Minimal residual disease – ready for prime time in follicular lymphoma?

High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Suchergebnisse filtern